- Country: Japan
- Summary: A Lenalidomide Hydrate 5Mg40capsules/Case about 500Cases,Ravulizumab (Genetical Recombination) 300Mg 3Mlvial about 900 Vials,Ravulizumab (Genetical Recombination) 1100Mg 11Mlvial about 120 Vial...
- JPT Ref No: 120944419
- Deadline: 15 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.:
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- A Lenalidomide Hydrate 5mg40capsules/case about 500cases,Ravulizumab (Genetical Recombination) 300mg 3mLvial about 900 vials,Ravulizumab (Genetical Recombination) 1100mg 11mLvial about 120 vial...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINA Lenalidomide Hydrate 5Mg40capsules/Case about 500Cases,Ravulizumab (Genetical Recombination) 300Mg 3Mlvial about 900 Vials,Ravulizumab (Genetical Recombination) 1100Mg 11Mlvial about 120 Vial... - Japan Tender
The NATIONAL UNIVERSITY CORPORATION, a Government sector organization in Japan, has announced a new tender for A Lenalidomide Hydrate 5Mg40capsules/Case about 500Cases,Ravulizumab (Genetical Recombination) 300Mg 3Mlvial about 900 Vials,Ravulizumab (Genetical Recombination) 1100Mg 11Mlvial about 120 Vial.... This tender is published on JapanTenders under JPT Ref No: 120944419 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-15.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
